Catalyst Wire Dossier Catalyst Wire Dossier

trimethoprim-sulfamethoxazole (TMP-SMX)

trimethoprim-sulfamethoxazole
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for trimethoprim-sulfamethoxazole (TMP-SMX), covering 2021-11-03 to 2021-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS [Phase 3]

See pricing